Environmental Allergy

Year round symptoms due to dust mites are experienced by millions of people. Dust mite allergens can be found throughout your house but most often live in warm, humid environments including beds, carpet, and upholstered furniture. These allergens can trigger a variety of symptoms including nasal, ocular, pulmonary, and skin inflammation. Because of this heterogeneity, diagnosis can be difficult. If dust mite or other indoor allergies are suspected, patients should consult a board certified allergist for further evaluation. This evaluation typically includes taking a detailed history including environmental exposure, physical exam and testing. Testing for dust mite allergies typically includes either a skin prick test or blood test (ImmunoCAP IgE) for the two main species of dust mites, Dermatophagoides pteronyssinus and Dermatophagoides farina.

Treatment for dust mite allergies includes reducing exposure to the allergen, pharmacotherapy, and immunotherapy. Allergy Partners has teamed with
Allergy Guardian to provide dust mite fabric covers for pillows, mattresses, and box springs. Removing carpet and regular vacuuming can help limit exposure to dust mites. Pharmacotherapy is guided by patient symptoms. This typically includes the use of oral or intranasal antihistamines and nasal corticosteroids for treatment of nasal symptoms. A step-wise approach for the treatment of asthma is recommended including the use of inhaled corticosteroids, long-acting 2 agonists, leukotriene modifiers and immunologic agents. Allergy immunotherapy by either subcutaneous injection or sublingual tablets is the most effective long term treatment for dust mite allergies available. Effective treatment with allergen specific immunotherapy has been shown to decrease the progression of respiratory allergic diseases and even prevent the development of asthma in children. For more information regarding the diagnosis and treatment of dust mite allergies, please call your local Allergy Partners office for an appointment.

Dr. Elizabeth Majeski

Allergy Partners of Charleston

Allergic rhinitis is an increasingly common condition with typical symptoms of itchy and runny nose, sneezing, nasal congestion, and postnasal drainage. Frequently brushed off as “a pesky runny nose”, it has been shown that allergic rhinitis is often not an isolated disorder, but coincides with a multitude of other conditions including asthma, sinusitis, conjunctivitis, chronic otitis media, tonsillar and adenoid hypertrophy, sleep apnea, snoring, pharyngitis, laryngitis and disordered sleep. Allergic rhinitis and related comorbidities often negatively impact quality of life.

Allergic rhinitis results from an abnormal immune response to substances encountered in the environment such as pollens, pet dander, mold, and droppings from dust mites and cockroaches. The incidence of allergic rhinitis is estimated at 10-30% of the world’s population and symptoms are often under-recognized and undertreated. It has also been shown that poorly controlled allergic rhinitis is an exacerbating factor for asthma based on a shared common inflammatory pathway and the concept of “one airway”. Controlling allergic rhinitis is a key to maintaining asthma control. Recurrent sinus infections and worsening conjunctivitis are also often related to uncontrolled allergic rhinitis.

Identifying specific allergens with allergy testing allows customization of a treatment plan to include avoiding allergens, medications, and immunotherapy. Immunotherapy is the only therapy that treats the underlying cause, hence not only reducing pesky nasal symptoms, but significantly impacting eye symptoms, asthma and all the other associated disorders. Studies have shown that treating allergic rhinitis with immunotherapy not only improves allergic asthma, but can prevent it from occurring by eliminating the immune system response to potential triggers.
Don’t brush off a runny nose. Likely there are many other related symptoms that can be influenced by adequately treating allergic rhinitis.

Madeline Dillon, MD
Allergy Partners of Charlottesville

References:
Hadley JA, Derebery MJ, Marple BF. Comorbidities and allergic rhinitis: not just a runny nose. J Fam Pract. 2012 Feb;61(2 Suppl):S11-5.

Meltzer EO, Gross GN, Katial R, Storms WW. Allergic rhinitis substantially impacts patient quality of life: Findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract. 2012;61(suppl 1):S5-S10.
World Health Organization. White Book on Allergy 2011-2012 Executive Summary. By Prof. Ruby Pawankar, MD, PhD, Prof. Giorgio Walkter Canonica, MD, Prof. Stephen T. Holgate, BSc, MD, DSc, FMed Sci and Prof. Richard F. Lockey, MD.
Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2010. By Jeannine S. Schiller, M.P.H., Jacqueline W. Lucas, M.P.H., Brian W. Ward, PhD and Jennifer A. Peregory, M.P.H., Division of Health Interview Statistics.
Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am. 2004;24(1):19-43.

There has been mounting evidence connecting exposure to secondhand smoke to illness and diseases due to the irritating nature of tobacco smoke on the non-smoker.

Despite significant educational efforts, epidemiologic evidence, and reports from the United States Surgeon General, smoking and smoking-related conditions are a major health concern. The irritating nature of tobacco smoke on the non-smoker has long been recognized. Since the 1960’s, there has been mounting evidence connecting exposure to secondhand smoke to illness and disease.
Secondhand smoke is a term used for the involuntary exposure of nonsmokers to tobacco smoke from smokers. Another commonly used term is Environmental Tobacco Smoke. Secondhand smoke is a mixture of side stream smoke given off by the smoldering cigarette, pipe, or cigar and mainstream smoke exhaled into the air by active smokers. Third hand smoke refers to smoke components deposited on surfaces.

In the News:

The Global Burden of Disease Study done in 2010 estimated that exposure to secondhand smoke is responsible for 601.000 premature deaths annually worldwide. It is estimated that 28% of the mortality and 61% of the morbidity is seen in children. Secondhand smoke has been found to be a cause of lung cancer by several epidemiologic studies. Cardiac disease has also been causally associated with secondhand smoke exposure in adults. Mounting evidence also points to secondhand smoke exposure as a cause or aggravator of a variety of adverse respiratory conditions including asthma, pneumonia, bronchitis, reduced lung function, sinusitis, and COPD. Secondhand smoke exposure is also implicated as a cause of middle ear disease, sensorineural hearing loss, sudden infant death syndrome, prematurity, impaired fetal growth and development, dental caries, cancers in locations other than the lungs, renal disease, and atherogenesis.

How It Can Affect Your Family:

The level of tobacco exposure of the fetus of a mother who smokes is the same as the level for an active smoker. There is a higher risk of stillbirth and neonatal deaths among newborns of smoking mothers. Maternal smoking during pregnancy reduces birth weight on an average of 200 grams. Active smoking of the mother during pregnancy is also associated with an increase in a large variety of non-chromosomal birth defects. Cognitive deficits tend to be more prevalent in children whose mothers smoked during pregnancy. Exposure of the non-smoking mother to secondhand smoke during pregnancy has been associated with an increased incidence of low birth weight, stillbirth, and congenital malformations.
The Global Study of Disease Burden from exposure to secondhand smoke estimates that 165,000 children under the age of 5 worldwide die annually because of lower respiratory infections attributed to secondhand smoke exposure. Chronic exposure to secondhand smoke is linked to an increased prevalence and severity of asthma. There is also evidence that secondhand smoke exposure promotes and facilitates allergic sensitization. Children with chronic secondhand smoke exposure enter adulthood with less pulmonary reserve and decreased lung function.
Exposure of children and adolescents to parental smoking has been associated with advancement of the vascular age by 3.3 years by measurement of carotid artery thickness. This increases the risk of developing carotid atherosclerotic plaques in adulthood even with adjustments being made for other risk factors such as blood pressure, lipid levels, and personal smoking status. There is growing concern about increased risks of coronary artery disease in adults and children exposed to secondhand smoke.

What Can I Do?

Reducing and preferably eliminating secondhand smoke in the home and in vehicles is critical since these are the major locations of exposure for children and non-smoking adults. Secondhand smoke cannot be controlled by air cleaning and filtration, or building ventilation. These findings on the effects of secondhand smoke are the foundation for the drive for smoke-free indoor environments and for educating parents and the community on the adverse health effects. Policies that ban all indoor smoking in workplaces and public places are highly effective in reducing smoke exposure. Only complete bans of smoking in indoor environments are effective. Segregation of smokers and non-smokers within the same indoor environment may reduce some of the exposure, but does not eliminate it.

Bonita Wilson, MD